Analysis of the relationship between RUNX2 expression and clinicopathological features of GC showed that high expression of RUNX2 was correlated with low differentiation of human GC (P < 0.05, Figure 1B and Table 1). This evidence concerns the gene RUNX2 and gastric cancer.